Lipocine, Inc. (LPCN)
2.315
+0.06
(+2.89%)
USD |
NASDAQ |
Sep 10, 15:25
Lipocine Price : 2.315 for Sept. 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 09, 2026 | 2.34 | 2.352 | 2.25 | 2.25 | 4811.00 |
| Sep 08, 2026 | 2.39 | 2.40 | 2.345 | 2.36 | 21137.00 |
| Sep 04, 2026 | 2.421 | 2.480 | 2.361 | 2.45 | 23182.00 |
| Sep 03, 2026 | 2.41 | 2.50 | 2.32 | 2.42 | 26672.00 |
| Sep 02, 2026 | 2.22 | 2.39 | 2.22 | 2.355 | 35050.00 |
| Sep 01, 2026 | 2.19 | 2.30 | 2.183 | 2.30 | 10017.00 |
| Aug 31, 2026 | 2.14 | 2.29 | 2.14 | 2.24 | 27530.00 |
| Aug 28, 2026 | 2.23 | 2.23 | 2.13 | 2.17 | 19546.00 |
| Aug 27, 2026 | 2.17 | 2.30 | 2.17 | 2.23 | 41550.00 |
| Aug 26, 2026 | 2.15 | 2.29 | 2.15 | 2.15 | 106047.0 |
| Aug 25, 2026 | 2.08 | 2.16 | 2.07 | 2.15 | 11788.00 |
| Aug 24, 2026 | 2.07 | 2.10 | 2.050 | 2.06 | 26725.00 |
| Aug 21, 2026 | 2.11 | 2.11 | 2.06 | 2.09 | 18218.00 |
| Aug 20, 2026 | 2.05 | 2.135 | 2.05 | 2.09 | 35160.00 |
| Aug 19, 2026 | 2.105 | 2.115 | 2.05 | 2.05 | 24869.00 |
| Aug 18, 2026 | 2.08 | 2.131 | 2.04 | 2.04 | 29109.00 |
| Aug 17, 2026 | 2.09 | 2.13 | 2.04 | 2.05 | 30290.00 |
| Aug 14, 2026 | 2.10 | 2.18 | 2.07 | 2.11 | 31388.00 |
| Aug 13, 2026 | 2.07 | 2.224 | 2.04 | 2.06 | 23727.00 |
| Aug 12, 2026 | 2.11 | 2.13 | 2.02 | 2.06 | 48969.00 |
| Aug 11, 2026 | 2.10 | 2.160 | 2.09 | 2.09 | 13317.00 |
| Aug 10, 2026 | 2.16 | 2.21 | 2.10 | 2.10 | 41493.00 |
| Aug 07, 2026 | 2.26 | 2.26 | 2.12 | 2.13 | 33856.00 |
| Aug 06, 2026 | 2.14 | 2.18 | 2.08 | 2.13 | 37012.00 |
| Aug 05, 2026 | 2.19 | 2.260 | 2.15 | 2.17 | 56199.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 266.50 |
| ANI Pharmaceuticals, Inc. | 70.53 |
| Corcept Therapeutics, Inc. | 114.49 |
| Veru, Inc. | 2.49 |
| Eli Lilly & Co. | 1124.34 |
Price Related Metrics
| PS Ratio | 9.634 |
| PEG Ratio | -0.0103 |
| Price to Book Value | 0.8768 |
| Earnings Yield | -80.52% |
| Market Cap | 19.09M |
| PEGY Ratio | -0.0103 |